COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,306 Articles (22,772 medRxiv, 8,534 bioRxiv)

Most recent first Previous |  Page 861: Articles 8601-8610  | Next

Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-Like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system
De Marco Verissimo, C., Lopez-Corrales, J., Dorey, A. L., Cwiklinski, K., Lalor, R., Calvani, N. E. D., Jewhurst, H. L., Doyle, S., Dalton, J. P.
10.1101/2022.03.25.485815 — Posted: 2022-03-25
A Qualitative Study Regarding Messages of the COVID-19 Vaccine from Vaccinated Healthcare Providers and Healthy Adults
Sano, S., Sato, S., Ohmagari, N., Takahashi, O.
10.1101/2022.03.24.22272878 — Posted: 2022-03-25
International comparison of the impact of the pandemic and vaccination measures adopted on children and adolescent population
Rajmil, L., Pinzon-Segura, M. C., Yaw Appiah, S. C., Ekpenyong, B., Gonzalez, F., Gundogdu, Z., Oncel, S., Cakici, O.
10.1101/2022.03.24.22272863 — Posted: 2022-03-25
Tracking population mental health before and across stages of the COVID-19 pandemic in young adults
Kwong, A. S. F., Northstone, K., Pearson, R. M., McIntosh, A. M., Timpson, N. J.
10.1101/2022.03.24.22272899 — Posted: 2022-03-25
Estimating time-dependent infectious contact: a multi-strain epidemiological model of SARS-CoV-2 on the island of Ireland
Kamiya, T., Alvarez-Iglesias, A., Ferguson, J., Murphy, S., Sofonea, M. T., Fitz-Simon, N.
10.1101/2022.03.25.22272942 — Posted: 2022-03-25
Risk factors and preventive interventions for post Covid-19 condition: systematic reviews
Pillay, J., Rahman, S., Guitard, S., Wingert, A., Hartling, L.
10.1101/2022.03.25.22272949 — Posted: 2022-03-25
Optimized infection control practices augment the robust protective effect of vaccination for ESRD patients during a hemodialysis facility SARS-CoV-2 outbreak
Meller, M. E., Pfaff, B. L., Borgert, A. J., Richmond, C. S., Athas, D. M., Kenny, P. A., Sabin, A. P.
10.1101/2022.03.18.22272356 — Posted: 2022-03-25
Impact assessment of mobility restriction, testing, and vaccination on the COVID-19 pandemic in India
Shin, J., Khuong, Q. L., Abbas, K., Oh, J.
10.1101/2022.03.24.22272864 — Posted: 2022-03-25
THE IMPACT OF ROUTINES ON EMOTIONAL AND BEHAVIOURAL DIFFICULTIES IN CHILDREN AND ON PARENTAL ANXIETY DURING COVID-19
Lees, V., Hay, R., Bould, H., Kwong, A. S. F., Smith, D., Kounali, D., Pearson, R.
10.1101/2022.03.25.22272950 — Posted: 2022-03-25
Vaccine effectiveness with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine against reported SARS-CoV-2 Delta and Omicron infection among adolescents, Norway, August 2021 to January 2022
Veneti, L., Berild, J. D., Viksmoen Watle, S., Starrfelt, J., Greve-Isdahl, M., Langlete, P., Boas, H., Bragstad, K., Hungnes, O., Meijerink, H.
10.1101/2022.03.24.22272854 — Posted: 2022-03-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).